The expression of receptor for hyaluronan-mediated motility (RHAMM) is regulated by the convergence of mevalonate and Hippo pathways onto YAP/TEAD, which controls RHAMM transcription and consequently supports breast cancer cell migration and invasion. This evidence concerns the gene HMMR and breast carcinoma.